The COVID-19 vaccine candidate being developed by Oxford University in collaboration with pharma company AstraZeneca is made from a weakened version of a common cold virus...
According to the Russian Direct Investment Fund, which bankrolled the development of Sputnik V COVID-19 vaccine, the cost per dose will be less than 10 USD...
As of November 24, more than 22,000 volunteers were vaccinated with the first dose and more than 19,000 volunteers with the first and the second dose...
The Central government has asked states to do planning and mapping of vaccination sessions where healthcare workers will be vaccinated during the first phase and mapping...
Trials of Oxford’s COVID-19 vaccine candidate, ChAdOx1 nCoV-2019, shows the vaccine is 70.4 per cent effective at preventing COVID-19 (SARS-CoV-2)
Here is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed more than 1.34 million lives worldwide
The vaccine developed by Oxford University was 90 per cent effective in preventing COVID-19 when it was administered as a half dose followed by a full...
In a statement, Pfizer and BioNTech said they expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses...
The state-run Indian Council of Medical Research (ICMR) and privately-held Bharat Biotech this month started third-stage trials of COVAXIN that would involve 26,000 volunteers
Bharat Biotech has partnered with the Indian Council of Medical Research (ICMR) for a country-made COVID-19 vaccine using the virus strain isolated by ICMR's National Institute...
According to Health minister Harsh Vardhan, coronavirus vaccine will be available in a couple of months and it is estimated that by July-August, 400-500 million vaccine...
According to experts, some vaccines, called vectored-vaccines, use viruses compatible with the human body to deliver the DNA or RNA of the novel coronavirus inside our...